Oklahoma Administrative Code Title 535 - Oklahoma State Board of Pharmacy
Title 535 – Oklahoma State Board of Pharmacy
Chapter 1: General Provisions
535:1-1-1 — Purpose and Scope
Establishes the authority and duties of the Oklahoma State Board of Pharmacy.
Regulates the practice of pharmacy, including dispensing, compounding, and distribution of drugs.
Ensures public safety and compliance with federal and state pharmacy laws.
535:1-1-2 — Definitions
Key terms include:
Board – Oklahoma State Board of Pharmacy.
Pharmacy – Establishment licensed to dispense prescription drugs.
Pharmacist – Individual licensed to practice pharmacy.
Drug – Any substance intended for use in diagnosis, treatment, or prevention of disease.
Prescription – Order from a licensed practitioner for drugs to be dispensed to a patient.
Chapter 2: Licensure and Registration
535:1-2-1 — Pharmacist Licensure
Requirements include:
Graduation from an accredited pharmacy school,
Completion of internship hours approved by the Board,
Passing the North American Pharmacist Licensure Examination (NAPLEX) and Multistate Pharmacy Jurisprudence Examination (MPJE),
Submission of application and fees.
535:1-2-2 — Pharmacy Licensure
Pharmacies must be licensed by the Board before operating.
Requirements include inspection, proper facilities, recordkeeping, and compliance with regulations.
535:1-2-3 — Technician Registration
Pharmacy technicians must register with the Board.
Requirements include education, training, and compliance with scope of practice.
535:1-2-4 — Renewal
Licenses for pharmacists, pharmacies, and technicians must be renewed periodically.
Renewal requires fees, continuing education, and compliance with Board rules.
Chapter 3: Standards of Practice
535:1-3-1 — Pharmacy Operations
Pharmacies must maintain proper storage, security, sanitation, and recordkeeping.
All prescription drugs must be accurately labeled and dispensed.
535:1-3-2 — Compounding
Compounding must follow professional standards and USP guidelines.
Compounded drugs must be prepared safely and accurately.
535:1-3-3 — Dispensing
Pharmacists must ensure accuracy and appropriateness of all prescriptions.
Counseling patients on medication use is required when necessary.
535:1-3-4 — Controlled Substances
Controlled substances are subject to federal and state regulations.
Prescriptions must be properly documented, stored, and reported to the Prescription Monitoring Program (PMP).
Chapter 4: Inspections and Enforcement
535:1-4-1 — Inspections
The Board conducts routine and unannounced inspections of pharmacies, records, and operations.
Inspections verify compliance with regulations and identify violations.
535:1-4-2 — Complaints
Complaints may be filed against pharmacists, technicians, or pharmacies for alleged violations.
Complaints are investigated by Board staff.
535:1-4-3 — Disciplinary Actions
Violations may result in:
Fines
License suspension or revocation
Probation
Mandatory corrective actions
Chapter 5: Continuing Education
535:1-5-1 — Requirements
Pharmacists must complete a minimum number of continuing education (CE) hours per renewal period.
CE courses must be Board-approved and relevant to pharmacy practice.
535:1-5-2 — Recordkeeping
Licensees must maintain CE records for verification during audits or inspections.
Chapter 6: Administration and Fees
535:1-6-1 — Board Structure
The Board consists of appointed members including licensed pharmacists and public representatives.
Members serve fixed terms and oversee licensing, enforcement, and regulation.
535:1-6-2 — Fees
Fees are established for licensure, registration, inspections, and renewals.
Fees may vary based on license type and duration.
535:1-6-3 — Rules and Policies
The Board may adopt rules and policies to implement regulatory authority, including clarifications for licensing, inspections, and professional conduct.
Chapter 7: Recordkeeping and Reporting
535:1-7-1 — Prescription Records
Pharmacies must maintain accurate prescription records for all dispensed medications.
Records must be accessible for inspection and retained according to retention schedules.
535:1-7-2 — Reporting to PMP
Pharmacies must report controlled substance prescriptions to the state Prescription Monitoring Program.
Reporting ensures monitoring and prevention of misuse or diversion.
This summary covers the core structure of Title 535, including licensure, standards of practice, inspections, continuing education, enforcement, administration, and recordkeeping.
RELATED Blog
comments